Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
59
CEE Quote, Financials, Valuation and Earnings
Last price:
$11.99
Seasonality move
:
-0.56%
Day range:
$11.31 - $12.14
52-week range:
$9.11 - $13.36
Dividend yield:
3.05%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
28.7K
Avg. volume:
35.6K
1-year change:
24.69%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Earnings Data
Next earnings date for CEE
--
Most recent earnings per share
--
Missed by --
(Dec 23/2024)
Consensus Estimate
--
(Dec 23/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CEE Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|
CENTRAL & EASTERN EUROPE FUND, INC. Earnings Questions
-
How Much did CENTRAL & EASTERN EUROPE FUND, INC. Generate in Revenue Last Quarter?
CENTRAL & EASTERN EUROPE FUND, INC. reported -- worth of top line sales in its most recent quarter.
-
Did CENTRAL & EASTERN EUROPE FUND, INC. Beat Earnings Last Quarter?
CENTRAL & EASTERN EUROPE FUND, INC. announced earnings per share of -- which represents a miss of analyst forecast a -- per share.
-
Is CENTRAL & EASTERN EUROPE FUND, INC. Profitable?
CENTRAL & EASTERN EUROPE FUND, INC. reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for CENTRAL & EASTERN EUROPE FUND, INC. EPS Next Year?
CENTRAL & EASTERN EUROPE FUND, INC.'s earnings are forecast to grow from -- per share to -- per share next year representing an increase of --.
-
When is CENTRAL & EASTERN EUROPE FUND, INC.'s Earnings Date?
Currently, CENTRAL & EASTERN EUROPE FUND, INC. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 24, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
